Article · Wikipedia archive · Last revised Aug 13, 2026

2C-DB

2C-DB, also known as 2,5-dimethoxy-4,6-dibromophenethylamine or as 6-bromo-2C-B, is a psychedelic drug of the phenethylamine and 2C families related to 2C-B. It is the 6-bromo derivative of 2C-B and the 4,6-dibromo derivative of 2,5-dimethoxyphenethylamine (2C-H). The drug has a dose range of 20 to 35 mg orally and a duration of 6 to 8 hours. For comparison, 2C-B has a dose of 12 to 24 mg and a duration of 4 to 8 hours. 2C-DB is described as having largely the same effects as 2C-B. However, it is said that the drug may have somewhat greater visual effects than 2C-B. 2C-DB was synthesized and tested by P. Rausch in the 1990s or 2000s. It was described in the scientific literature by Daniel Trachsel in 2013, who cited personal communication with Rausch as the source for the information. The drug is a controlled substance in Canada under phenethylamine blanket-ban language.

Last revised
Aug 13, 2026
Read time
≈ 1 min
Length
290 w
Citations
12
Source
Wikipedia ↗
2C-DB
Clinical data
Other names2-Bromo-2C-B; 2,5-Dimethoxy-4,6-dibromophenethylamine; 2,4-Dibromo-3,6-dimethoxyphenethylamine
Routes of
administration		Oral1
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • None
Pharmacokinetic data
Duration of action6–8 hours1
Identifiers
  • 2-(2,4-dibromo-3,6-dimethoxyphenyl)ethan-1-amine
Chemical and physical data
FormulaC10H13Br2NO2
Molar mass339.027 g·mol−1
3D model (JSmol)
  • NCCc1c(OC)cc(c(c1Br)OC)Br
  • InChI=1S/C10H13Br2NO2/c1-14-8-5-7(11)10(15-2)9(12)6(8)3-4-13/h5H,3-4,13H2,1-2H3
  • Key:ISCLQOQPPGRPTK-UHFFFAOYSA-N

2C-DB, also known as 2,5-dimethoxy-4,6-dibromophenethylamine or as 6-bromo-2C-B, is a psychedelic drug of the phenethylamine and 2C families related to 2C-B.1 It is the 6-bromo derivative of 2C-B and the 4,6-dibromo derivative of 2,5-dimethoxyphenethylamine (2C-H).1 The drug has a dose range of 20 to 35 mg orally and a duration of 6 to 8 hours.1 For comparison, 2C-B has a dose of 12 to 24 mg and a duration of 4 to 8 hours.1 2C-DB is described as having largely the same effects as 2C-B.1 However, it is said that the drug may have somewhat greater visual effects than 2C-B.1 2C-DB was synthesized and tested by P. Rausch in the 1990s or 2000s.12 It was described in the scientific literature by Daniel Trachsel in 2013, who cited personal communication with Rausch as the source for the information.1 The drug is a controlled substance in Canada under phenethylamine blanket-ban language.3

See also

See also

References

References

  1. Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag. p. 921. ISBN 978-3-03788-700-4. OCLC 858805226. Archived from the original on 21 August 2025.
  2. Rausch P (January 1995). Leuner H, Schlichting M (eds.). Jahrbuch des Europäischen Collegiums für Bewußtseinsstudien: 1995 [Yearbook of the European College for the Study of Consciousness: 1995] (in German and English). Vol. 4. Berlin: VWB. ISBN 3861354071. ISSN 0942-7600. OCLC 28636362.
  3. "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
External links